Global Next Generation Sequencing Market Size, Share & Trend Analysis- By Technology, By Application, By Workflow, By End-User, Regional Outlook, Competitive Tactics, and Segment Forecast to 2031

The Global Next Generation Sequencing Market size was estimated at USD 6.37 billion in 2021 and is expected to hit around USD 24.48 billion by 2031, poised to grow at a compound annual growth rate (CAGR) of 16.1% from 2022 to 2031.

Global Next Generation Sequencing Market: Breakup by Region, 2022 & 2031

Diagram Description automatically generated with low confidence

Source: Primary Research and Secondary Research Analysis

The research, production, distribution, and use of cutting-edge DNA and RNA sequencing technologies, as well as associated goods and services, are collectively referred to as the "Global Next Generation Sequencing (NGS) Market." The next generation of DNA and RNA sequencing, commonly referred to as high-throughput sequencing, makes it possible to analyse genetic material quickly and effectively. It has uses in many different industries, including agriculture, clinical diagnostics, drug discovery, and genomics research.

The Next Generation Sequencing (NGS) landscape is being shaped by a number of important factors in the current global market environment. First and foremost, sequencing technologies constantly strive to be faster and more precise. Manufacturers are always coming up with new technologies to provide platforms that can process larger volumes of genetic data with more accuracy, allowing researchers to delve deeper into challenging biological issues.

Additionally, the NGS market is seeing an increasing focus on clinical applications and personalised medicine. Patient care has been revolutionised by the ability of NGS to analyse individual genomes, which has paved the possibility for customised medical treatments and targeted therapies. The fusion of genetics and healthcare has sparked collaborations between sequencing businesses and healthcare organisations, accelerating the use of NGS in clinical settings.

Another important development is the democratisation of sequencing, which involves initiatives to make NGS more widely available and reasonably priced. Due to this, small, portable sequencers have become available, allowing researchers and healthcare workers to do sequencing in settings with limited resources.

Download Free Sample Report

Recent Developments:

The environment of genetic analysis and research has recently undergone rapid changes due to the Global Next Generation Sequencing (NGS) Market. The constant improvement of long-read sequencing technologies is one notable development. Longer DNA segments can now be read by sequencers made by companies like Oxford Nanopore and PacBio, enabling more precise genome assembly and thorough structural variation analysis.

A noteworthy trend is the incorporation of NGS in clinical diagnosis. Regulatory approvals for NGS-based assays to identify diverse genetic abnormalities, cancer mutations, and infectious diseases are increasing. This is revolutionising patient care and treatment approaches by improving the accuracy and early diagnosis of medical disorders.

Another significant breakthrough is the fusion of NGS with data analytics and artificial intelligence. Utilising cutting-edge machine learning techniques and bioinformatics tools, significant insights are being gleaned from the enormous datasets produced by NGS. This facilitates the discovery of novel biomarkers, the identification of disease-associated genetic variants, and the prediction of treatment responses.

Additionally, there is more cooperation between pharmaceutical businesses and sequencing companies in the NGS sector. Through the use of NGS data, our alliance intends to speed up the identification of new therapeutic targets and the evaluation of drug efficacy.

 

Table of Content

Global Next Generation Sequencing Industry Research Report, 2020-2031.

  1. 1. Introduction
    1. Report description
    2. Key market segments
    3. Regional Scope
    4. Executive Summary
  2. 2. Research Methodology
    1. Secondary Research
    2. Primary Research
    3. Secondary Analyst Tools and Models
  3. 3. Market Dynamics
    1. Market driver analysis
    2. Market restraint analysis
    3. Market Opportunity   
    4. Market Challenges
    5. Impact analysis of COVID-19 on the Next Generation Sequencing Industry
  4. 4. Market Variables and Outlook
    1. SWOT Analysis
      1. Strengths
      2. Weaknesses
      3. Opportunities
      4. Threats
    2. Supply Chain Analysis
    3. PESTEL Analysis
      1. Political Landscape
      2. Economic Landscape
      3. Social Landscape
      4. Technological Landscape
      5. Environmental Landscape
      6. Legal Landscape
    4. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitute
      4. Threat of New Entrant
      5. Competitive Rivalry
  5. 5. Next Generation Sequencing Industry: Technology Estimates & Trend Analysis
    1. Next Generation Sequencing Industry value share and forecast, (2020 to 2031)
    2. Incremental Growth Analysis and Infographic Presentation
    3. Illumina Sequencing
      1. Market Size & Forecast, 2020-2031
    4. Ion Torrent Sequencing
      1. Market Size & Forecast, 2020-2031
    5. Pacific Biosciences Sequencing
      1. Market Size & Forecast, 2020-2031
    6. Oxford Nanopore Sequencing
      1. Market Size & Forecast, 2020-2031
  6. 6. Next Generation Sequencing Industry: Application Estimates & Trend Analysis
    1. Next Generation Sequencing Industry value share and forecast, (2020 to 2031)
    2. Incremental Growth Analysis and Infographic Presentation
    3. Genomics Research
      1. Market Size & Forecast, 2020-2031
    4. Clinical Diagnostics
      1. Market Size & Forecast, 2020-2031
    5. Drug Discovery
      1. Market Size & Forecast, 2020-2031
    6. Agriculture
      1. Market Size & Forecast, 2020-2031
    7. Forensic Analysis
      1. Market Size & Forecast, 2020-2031
  7. 7. Next Generation Sequencing Industry: Workflow Size Estimates & Trend Analysis
    1. Next Generation Sequencing Industry value share and forecast, (2020 to 2031)
    2. Incremental Growth Analysis and Infographic Presentation
    3. Sample Preparation
      1. Market Size & Forecast, 2020-2031
    4. Library Preparation
      1. Market Size & Forecast, 2020-2031
    5. Sequencing
      1. Market Size & Forecast, 2020-2031
    6. Data Analysis
      1. Market Size & Forecast, 2020-2031
  8. 8. Next Generation Sequencing Industry: End-User Estimates & Trend Analysis
    1. Next Generation Sequencing Industry value share and forecast, (2020 to 2031)
    2. Incremental Growth Analysis and Infographic Presentation
    3. Research Institutions
      1. Market Size & Forecast, 2020-2031
    4. Academic Laboratories
      1. Market Size & Forecast, 2020-2031
    5. Clinical Laboratories
      1. Market Size & Forecast, 2020-2031
    6. Pharmaceutical Companies
      1. Market Size & Forecast, 2020-2031
    7. Biotechnology Firms
      1. Market Size & Forecast, 2020-2031
  9. 9. Next Generation Sequencing Industry: Regional Estimates & Trend Analysis
    1. Next Generation Sequencing Industry value share and forecast, (2020 to 2031)
    2. Incremental Growth Analysis and Infographic Presentation
    3. North America
      1. Market Size & Forecast, 2020-2031
    4. Europe
      1. Market Size & Forecast, 2020-2031
    5. Asia Pacific
      1. Market Size & Forecast, 2020-2031
    6. Middle East & Africa
      1. Market Size & Forecast, 2020-2031
    7. Latin America
      1. Market Size & Forecast, 2020-2031
  10. 10. Next Generation Sequencing Industry: Country Estimates & Trend Analysis
    1. Next Generation Sequencing Industry value share and forecast, (2020 to 2031)
    2. Incremental Growth Analysis and Infographic Presentation
    3. U.S.
      1. Market Size & Forecast, 2020-2031
    4. Canada
      1. Market Size & Forecast, 2020-2031
    5. Mexico
      1. Market Size & Forecast, 2020-2031
    6. UK
      1. Market Size & Forecast, 2020-2031
    7. France
      1. Market Size & Forecast, 2020-2031
    8. Germany
      1. Market Size & Forecast, 2020-2031
    9. Russia
      1. Market Size & Forecast, 2020-2031
    10. Italy
      1. Market Size & Forecast, 2020-2031
    11. Spain
      1. Market Size & Forecast, 2020-2031
    12. China
      1. Market Size & Forecast, 2020-2031
    13. India
      1. Market Size & Forecast, 2020-2031
    14. Japan
      1. Market Size & Forecast, 2020-2031
    15. Indonesia
      1. Market Size & Forecast, 2020-2031
    16. South Korea
      1. Market Size & Forecast, 2020-2031
    17. Australia
      1. Market Size & Forecast, 2020-2031
    18. Brazil
      1. Market Size & Forecast, 2020-2031
    19. Argentina
      1. Market Size & Forecast, 2020-2031
    20. Saudi Arabia
      1. Market Size & Forecast, 2020-2031
    21. UAE
      1. Market Size & Forecast, 2020-2031
    22. South Africa
      1. Market Size & Forecast, 2020-2031
  11. 11. Competitive Landscape
    1. Company Market Share Analysis
    2. Vendor Landscape
    3. Competition Dashboard
  12. 12. Company Profiles
    1. Business Overview, Product Landscape, Financial Performanceand Company Strategies for below companies
    2.     Illumina Inc.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    3. Thermo Fisher Scientific Inc.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    4. Pacific Biosciences of California, Inc.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    5. Oxford Nanopore Technologies Ltd.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    6. Agilent Technologies Inc.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    7. Roche Holding AG
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    8. Qiagen N.V.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    9. BGI Group
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    10. PerkinElmer Inc.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    11. Bio-Rad Laboratories, Inc.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    12. F. Hoffmann-La Roche Ltd.
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    13. Eurofins Scientific SE
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    14. Beijing Genomics Institute
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    15. Genewiz
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
    16. ArcherDX
      1. Company Overview
      2. Financial Performance
      3. Product Benchmarking
      4. Geographic Footprint
      5. Strategic Initiatives
  13. 13. Conclusion


In case you don’t find what, you are looking for, please get in touch with our custom research team at sales@organicmarketresearch.com or Download Free Sample Report

  • Buy Now

Speak To Consultant

or Face to Face Meeting

Why Choose Us

  • 24x7 Post-Sales Support
  • 4000+ Reports Repository
  • 10% Free Customization
  • Large Network Of Industry Experts
  • Deep Sector Specific Intelligence
  • Unique Mix Of Global, Regional And Country Specific Reports

Related Reports

Recent News

Why Buy From Us?

Succeed

Our reports with in-depth insights will equip you to succeed in your business plans.

Instant Access

Get instant access to the information you need to make the right decision.

Opportunities

Explore where opportunities lie for you and mitigate the risks.

Trusted

We are one of the most trusted brands setting benchmarks of excellence.